DANIELLE KNIGHT: Open Payments
NPI 1013561190 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 16 payments from 7 companies in 2025. Trend: 2023 $496 · 2024 $700 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 4 | $163 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| Organogenesis Inc. | 2 | $81 |
| Urgo Medical North America, LLC | 2 | $50 |
| Solventum Corporation | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
| Smith+Nephew, Inc. | 1 | $18 |
Products named: NUZYRA, TRELEGY ELLIPTA, APLIGRAF, AFFINITY, VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP, ACTIV.A.C., URGOCLEAN AG, DALVANCE.
Industry payments across NJ — which companies pay providers there.
